1 / 47

Sleep Apnea:

Sleep Apnea:. C Tyler. Sleep Apnea. Kaiser SF Sleep Lab a.k.a. ‘ apnea clinic ’ Part 4 C Tyler, Sep 2016 Medical Director Kaiser, San Francisco. Alternative Therapies:. CPAP Gold Standard M ost effective Titratable (auto) Verifiable (compliance) Safe. Positional Therapy

afisher
Télécharger la présentation

Sleep Apnea:

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Sleep Apnea: • C Tyler

  2. Sleep Apnea Kaiser SF Sleep Lab a.k.a. ‘apnea clinic’ Part 4 C Tyler, Sep 2016 Medical Director Kaiser, San Francisco

  3. Alternative Therapies: • CPAP • Gold Standard • Most effective • Titratable (auto) • Verifiable (compliance) • Safe Positional Therapy Weight Loss Smoking Cessation Treat Allergy Treat Acromegaly Treat Hypothyroid Oral Appliance (M.A.D.) Provent Surgery

  4. Weight Loss

  5. Positional Therapy

  6. Allergy Rx / Stop Smoking

  7. Provent

  8. Surgery: UPPP • Irreversible • Pain, Death • Oro-nasal reflux • Voice change • 50% “effective” • Surgical Literature: • ‘Efficacy’ = 50% reduction in AHI

  9. Genioglossus advancement

  10. Maxillo-mandibular advancement

  11. Oral Appliances • Mechanical Mandibular Advancement - ‘Jaw Thrust • Efficacy - 50% • Compliance - ? Better ? • Complications - TMJ, discomfort….

  12. Oral Appliance • AASM recommendations: • mild-to-moderate OSA (AHI < 25), • severe OSA who are intolerant or refuse CPAP • Good dentition: no periodontal disease • $1600 vs $800 for CPAP • 50% effective 50% of the time

  13. Hypoglossal Nerve Stimulator • Recently FDA approved • Propofol Endoscopy • $40,000 • No long term data

  14. Benefits of Treatment: • Sleep Quality • Quality of wakefulness (and of life) • Cardiovascular risk reduction

  15. OSA as a CardiovascularRisk Factor • Hypoxia • Adrenergic discharge • Sleep Fragmentation

  16. HTN • ? 70% with essential HTN have OSA • ? 80% with refractory HTN have OSA • ? 50% with HFrEF or HFpEF have OSA

  17. Hypertension and OSA

  18. Cardiovascular Eventsin untreated OSA • 7 year follow up study of healthy middle aged men • Event = new CAD, HTN, MI, Stroke, CV Death

  19. OSA+CHF: Probability of hospitalization or death in 5 years

  20. CSA + SHF:CPAP responders vs non-responders

  21. Cardiovascular Endpoints: • CONCLUSIONS • Therapy with CPAP plus usual care, as compared with usual care alone, did not prevent cardiovascular events in patients with moderate-to-severe obstructive sleep apnea and established cardiovascular disease. • Average CPAP use < 4 hr per night • Inadequate treatment = no benefit

  22. Summary: • OSA causes sleep deprivation • OSA causes oxidative vascular injury • Treatment of OSA • reduces risk of cardiovascular events • reduces motor vehicle accidents • CPAP is the Gold Standard • Alternative treatments exist • for those intolerant of CPAP

  23. Thank you - Chris Tyler

  24. Quiz: • How long do Ducks sleep? • Stanley Kubrick’s work on crime and punishment. • Over geologic and evolutionary time, days are getting (longer:shorter)? • The supra-chiasmatic nucleus responds to (light, melatonin, a $100,000 drug) • Caffeine antagonizes adenosine (yes/no)

  25. The End

  26. CPAP and Heart Failure • CANPAP trial: no benefit to CPAP in CHF+CSR • f/u paper showed improved outcome IF marked reduction in AHI

  27. Cheyne-Stokes respirations • Crescendo-decrescendo • Arousal at peak hyperpnea • PLM coexists in 85% • 20-40% of HFrEF • Hypocapneic (high loop gain) • Resolves in REM sleep (reduced loop gain) • CPAP reduces catechol levels and increases LVEF

  28. Hypoventillation Syndromes • Ondine’s Curse: Central Congenital Hypoventillation • Primary Alveolar Hypoventillation

  29. Central Apnea: • Periodic breathing at altitude • Sleep transition apneas • Any fragmentation of sleep • (insomnia, PLMS, pain, ) • Treatment emergent central apneas • CO2 falls below apnea threshold • Frequently resolves with time • narcotic-induced central apnea

  30. Future Opportunities: • Linkage to Obesity Efforts • nutritionist, metabolic clinic, etc. • Regional Registry • Population Management Tools • Comprehensive follow-up program • Questionnaire • Oximetry, Repeat diagnostics • Re-titrations • Compliance checks • New technologies - ie telephonic monitoring

  31. MRI x-section

  32. Cheyne-Stokes Resp • Periodic Breathing • Arterial BP • Sympathetic activity • (note: C-S resp is not a hypercarbic condition)

  33. Prevalence of OSA/CSA in SHF • Prevalence is higher in men

  34. CHF: Cheyne-Stokes Resp • Modest hypoxemia • Not associated with hypercarbia

  35. Prevelence of CSA in LV dysfunction

  36. CSA and probability of death

  37. Rx of SRBD in Systolic HF • Optimize HF Rx • O2 • Resp stimulants • (CO2??) • CPAP/BiPAP • adaptive pressure support servoventilation

  38. NC O2 reduces AHI in SHF

  39. CPAP troubles: air leak

  40. When REM goes Bad Figure: Neuropharmacologic and neurochemical control of cataplexy and excessive daytime sleepiness. Cataplexy, like REM sleep, regulated by balance of adrenergic and cholinergic tone.

  41. preoptic area (POA) lesions • loss of circadian sleep • Sustained wake state

  42. Encephalitis Lethargica

  43. Pharmacologic • Amphetamine – blocks DA/NE reuptake • Caffeine – antagonized Adenosine • Modafinil - – blocks DA/NE reuptake

  44. Follow-up and Compliance • Annual checks (ideal) • If significant weight gain or loss (+/- 10%) • Return of symptoms • Machine / mask problems • Compliance Check: • AHI, hrs of use, average use • Questionnaire: sx, sleep quality, problems

  45. Sleep Latency (MSLT) and sleep deprivation

  46. OSA epi-phenomena • REM rebound • Sleep transition phenomena

More Related